BRENNEN

Industries / Health / Healthcare / Fertility clinics

Stimulation and egg retrieval

Using hormone drugs to ripen several eggs at once, timing their final ripening, and collecting them from the ovaries with a fine needle.

7

Milestones achieved, from 1962 to 2016.

3

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 1962

    Hormones from urine

    Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are the pituitary hormones that ripen eggs. In 1958 Gemzell extracted FSH from the pituitary glands of human cadavers, but those products were dropped in the 1980s over short supply and the risk of Creutzfeldt-Jakob disease. In 1962 Bruno Lunenfeld and colleagues reported the first pregnancy after ovulation was induced with human menopausal gonadotropin (hMG), FSH and LH extracted from the urine of women past menopause and sold by Serono as Pergonal, followed by hCG; this became the standard way to induce ovulation. From 1995 recombinant FSH, made in cell cultures, was licensed in the EU and no longer depended on collected urine.

    LessonA drug taken from human tissue carries that tissue's risks.

    pmc.ncbi.nlm.nih.gov

    Credit

    Bruno Lunenfeld; Serono

  2. 1981

    Ripening several eggs

    The first IVF births used a woman's natural cycle and its single egg. A 2019 review counts one pregnancy per 101 attempts for that approach. In 1981 Howard W. Jones Jr. and Georgeanna Seegar Jones, of the IVF program at Norfolk, Virginia, gave hMG and then hCG to ripen several eggs at once, and the review counts one pregnancy per three attempts. Stimulating many follicles became the standard in IVF worldwide.

    pmc.ncbi.nlm.nih.govebi.ac.uk

    Credit

    Howard W. Jones Jr. and Georgeanna Seegar Jones

  3. 1984

    An egg from a donor

    A woman whose ovaries had failed was given estrogen and progesterone in sequence to prepare her uterus. A donated egg was fertilized with her husband's sperm, grown to the two-cell stage and placed in her uterus, and she delivered a healthy child, reported in Nature in 1984. The authors wrote that the method allows treatment of infertility caused by ovarian failure.

    ebi.ac.uk

    Credit

    P. Lutjen, A. Trounson and colleagues

  4. 1985

    Eggs collected through the vagina

    Early IVF collected eggs by laparoscopy, an operation through the abdomen under general anesthesia. P. Dellenbach and colleagues passed a needle through the wall of the vagina into the ovary, guided by an ultrasound scanner on the abdomen, under local anesthesia, in more than 100 patients, and reported five children born. They wrote that egg collection could now be done as an outpatient procedure.

    ebi.ac.uk

    Credit

    P. Dellenbach and colleagues

  5. 1991

    Eggs ripened in the lab

    In vitro maturation (IVM) collects immature eggs and ripens them in a dish, so that little or no hormone stimulation is needed. K. Y. Cha and colleagues matured 270 immature eggs from 23 ovaries removed for other reasons, fertilized them, and transferred five embryos to a woman whose ovaries had failed; she delivered healthy triplet girls. In 2013 the American Society for Reproductive Medicine (ASRM) said IVM should be done only as an experiment; its 2021 opinion, replacing that one, says results "suggest the potential for wider clinical application".

    ebi.ac.ukebi.ac.ukebi.ac.uk

    Credit

    K. Y. Cha and colleagues; ASRM

  6. 2005

    A safer trigger, at first

    Ovarian hyperstimulation syndrome (OHSS) is an overreaction to fertility drugs, driven by the usual final "trigger" shot of hCG, which makes blood vessels in the ovary leak. In a trial of 122 women, triggering with a drug of another class, a GnRH agonist, gave more mature eggs, but clinical pregnancies fell to 6% from 36% and 79% of early pregnancies were lost, most likely because the hormone support of the womb collapsed. In 2011 P. Devroey proposed an "OHSS-free clinic" built on the agonist trigger; the approach that took hold pairs it with freezing every embryo for later transfer, and ESHRE's guideline now recommends that pairing for women at risk of OHSS, and recommends against the agonist trigger for most patients having a fresh transfer.

    LessonA change that removed one danger broke another part of the cycle, and it worked only once the embryos were frozen.

    ebi.ac.ukebi.ac.ukpmc.ncbi.nlm.nih.gov

    Credit

    P. Humaidan and colleagues; P. Devroey; ESHRE

  7. 2016

    A dose set by AMH

    On 12 December 2016 the European Commission authorized Rekovelle (follitropin delta), an FSH whose daily dose is set from the woman's AMH level and body weight rather than chosen by the doctor. In its trial, ESTHER-1, with 1,329 women, ongoing pregnancy was 30.7% against 31.6% for standard dosing, with fewer excessive responses and fewer steps taken to prevent OHSS (2.3% against 4.5%). A 2026 review of everyday use at a Dutch center, Erasmus University Medical Centre, found 30.8% ongoing pregnancy per started cycle, the same as the trial.

    LessonDosing by a measured marker did not raise pregnancy rates; its gain was safety.

    ema.europa.euebi.ac.ukebi.ac.uk

    Credit

    A. Nyboe Andersen and the ESTHER-1 study group; Erasmus MC

Watch for

  1. Eggs ripened by stem cells

    Gameto's Fertilo uses support cells grown from induced pluripotent stem cells, adult cells reprogrammed to an embryonic-like state, to ripen eggs outside the body. The company says this cuts hormone injections from about two weeks to two or three days, that Fertilo is cleared for sale in many countries outside the US and used in clinics in Peru, Mexico and Australia, and that its US Phase 3 trial, FIRST, has begun. The trial plans 500 patients, compares Fertilo with an existing IVM product, MediCult IVM, on ongoing pregnancy at 12 weeks, and lists primary completion in May 2027.

    Achieved whenFIRST is published in a peer-reviewed journal showing more ongoing pregnancies than MediCult IVM, or a regulator approves Fertilo on that evidence.

    biospace.comclinicaltrials.gov

    Claimed by

    Gameto, August 2025

  2. AI picks the trigger day

    Two randomized trials are testing whether software should choose the day of the trigger shot, against the doctor's choice. FertilAI's trial at Herzliya Medical Center in Israel began in May 2025 with 180 patients planned; the AI-TOP trial of the STIMAI software began at five Dexeus clinics in Spain in April 2026 with 644 planned; both count mature eggs. An earlier study at a Michigan clinic, with past patients as the comparison, found that doctors using Alife Health's Stim Assist prescribed less FSH (397 against 444 IU to start) with the same number of mature eggs. ESHRE's guideline says follicle size as a trigger criterion "has not been sufficiently studied".

    Achieved whena randomized trial reports more mature eggs or more births with AI-chosen days, and a second center confirms it.

    clinicaltrials.govclinicaltrials.govpmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.gov

    Claimed by

    FertilAI, May 2025; Fundación Dexeus, April 2026

  3. Cheaper US fertility drugs

    Under an October 2025 deal with the White House, EMD Serono agreed to sell Gonal-f (an FSH), Ovidrel (an hCG trigger) and Cetrotide (a drug that stops early ovulation) on the government site TrumpRx.gov, at up to 84% off when all three are used in a typical protocol, by the company's account. The government's Centers for Medicare and Medicaid Services estimated savings of up to $2,200 per cycle on drugs that often cost over $5,000. At the site's launch in February 2026 the White House gave Gonal-f "as low as $168 per pen" and Cetrotide $22.50, down from $316.

    Achieved whenindependent data, such as a survey of patients' receipts or a published pharmacy price study, show what US patients paying cash spend on one cycle's drugs before and after.

    whitehouse.govhealio.comwhitehouse.gov

    Claimed by

    The White House and EMD Serono, October 2025 and February 2026

Open

  1. 01

    A test bench for dosing

    An open-source simulator of ovarian stimulation with a population of virtual patients, calibrated only to published trial results, on which any starting-dose or trigger-day rule can be run and scored for eggs collected and for overresponse. Doctors' rules of thumb, published dosing formulas and AI tools would all be scored on the same virtual patients.

    The brief
    Credit · unclaimed
  2. 02

    A world drug price table

    A public, dated table of what one stimulation's drugs cost in 25 countries: the list price per 75 IU of each FSH brand and copy (biosimilar), per dose of the drugs that block early ovulation, and per trigger shot, taken from official price lists and pharmacy sites, with the cost of one standard protocol worked out in local currency and US dollars.

    The brief
    Credit · unclaimed

Open 01 · the brief

A test bench for dosing

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

An open-source simulator of ovarian stimulation with a population of virtual patients, calibrated only to published trial results, on which any starting-dose or trigger-day rule can be run and scored for eggs collected and for overresponse. Doctors' rules of thumb, published dosing formulas and AI tools would all be scored on the same virtual patients.

Why it is still open

Mathematical models exist. Fischer, Röblitz and colleagues (Frontiers in Endocrinology, 2021) modeled hormones and the growth of each follicle and reproduced stimulation protocols in outline, but their simulated late-cycle stimulation ran several days shorter than in clinics, and they could not model dose changes because published trials do not state the rules used. A later model by Sophie Fischer-Holzhausen and Susanna Röblitz, GynCycle (Journal of Theoretical Biology, 2022), is public on GitHub as MATLAB code under the MIT License, with a switch to run cycles with or without drug treatment; it scores no dosing rules. A 2021 preprint ran computer-simulated trials to tailor one phase of an IVF protocol, the downregulation phase, to individual virtual patients. An agent-based AI model from the University of St Andrews and colleagues, published in the Journal of Clinical Endocrinology & Metabolism in 2026, learned follicle growth from 434,082 follicles at 11 European clinics and predicted final follicle sizes within 2 mm in 75% to 80% of cases; it was built on patient records and is not a public bench. This search found none that scores dosing rules against each other, and ESHRE's guideline notes "the lack of evidence of the value of dose adjustments".

pmc.ncbi.nlm.nih.govgithub.comexport.arxiv.orgresearch-portal.st-andrews.ac.ukpmc.ncbi.nlm.nih.gov

Built with what exists

The published equations of the 2021 model, with GynCycle's open code as a reference; Python with SciPy; published arm-level results for calibration, such as egg counts in both arms of ESTHER-1; an AI coding agent to turn the paper's equations into tested code. The advance is coding agents that implement a published model and check it against the paper's own figures.

  1. First step

    Code the 2021 model's equations and reproduce its published natural-cycle figure.

  2. Done looks like

    The simulator reproduces the mean and spread of eggs collected in both ESTHER-1 arms within 10%; at least five published dosing rules are scored on the same 10,000 virtual patients; the code is public, and an outside group reruns it and gets the same scores.

Open 02 · the brief

A world drug price table

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public, dated table of what one stimulation's drugs cost in 25 countries: the list price per 75 IU of each FSH brand and copy (biosimilar), per dose of the drugs that block early ovulation, and per trigger shot, taken from official price lists and pharmacy sites, with the cost of one standard protocol worked out in local currency and US dollars.

Why it is still open

The comparisons found use whole-cycle cost estimates; a 2021 study across the USA, UK, the Nordic countries, Spain and China took its per-cycle figures from estimates published by the website IVF-Worldwide. US patients have kept a crowd-sourced spreadsheet of cash prices per unit since August 2019, one country and unchecked. US prices moved in 2026 with TrumpRx. This search found no table of drug prices per unit across countries.

pmc.ncbi.nlm.nih.govdocs.google.comwhitehouse.gov

Built with what exists

National drug price lists and reimbursement tariffs where they are public; pharmacy price pages; the open-source web agent Browser Use 1.0 to collect them (see the Note "Deleting 80% to start over"); a spreadsheet; a person checking every price against its page.

  1. First step

    Collect the prices of Gonal-f, Menopur, Cetrotide and Ovidrel in five countries that publish drug price lists.

  2. Done looks like

    25 countries and 8 products, each price linked to its dated source; the cost of one standard protocol (150 IU of FSH a day for 10 days, five doses of an ovulation blocker, one trigger) for each country; the table rebuilt six months later; a second person's spot check of 10% of prices finds errors in no more than 2%.